arrow
M

Michael F. Gensheimer

stanford medicine
H指数:28
被引数:3,245

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Phase 1a clinical trial of XRD-0394, a first-in-class dual ATM/DNA-PK inhibitor, in combination with palliative radiotherapy

XRD-0394(一种首创的ATM/DNA-PK双抑制剂)与姑息性放疗联合治疗的1a期临床试验

2026-09-110
OA
Holistic evaluation of large language models for medical tasks with MedHELM

使用MedHELM对医疗任务的大型语言模型进行整体评估

2026-01-200
PRE
Local Control in Thoracic Stereotactic Ablative Radiotherapy: Analysis of Motion Management and Single Fraction Dosimetry from the iSABR trial

胸腺立体定向消融放射治疗中的局部控制:iSABR试验中运动管理与单次分割剂量学分析

2025-12-170
PRE
Adjuvant radiation is associated with reduced risks of local recurrence and nodal metastasis in high-risk localized cutaneous squamous cell carcinoma: a retrospective multicenter cohort study

辅助放疗与高危局限性皮肤鳞状细胞癌局部复发和淋巴结转移风险降低相关:一项回顾性多中心队列研究

2025-10-220
PRE
A Precise Reirradiation Supporting Tool Initiative (PRISTIN) for Prescribing Absorbed Dose and Number of Fractions in Reirradiation

精确再放疗支持工具倡议(PRISTIN)——用于规定再放疗中的吸收剂量和分割次数

2025-10-010
OAAI
Self-Perceived Hearing Outcomes with Radiation and Cisplatin or Radiation and Cetuximab for Patients with HPV-Positive Oropharyngeal Cancer – Results from xxxxx

自评听力结局:HPV阳性口咽癌患者接受放疗联合顺铂或放疗联合西妥昔单抗治疗的结果——来自xxxxx的研究

2025-08-180
PRE
A Phase 2 Single-Arm Trial of High-Dose Precision Targeted Radiation Therapy Added to Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer

一项针对转移性非小细胞肺癌患者的二期单臂临床试验,研究将高剂量精准靶向放射疗法加入免疫治疗的效果。

2025-03-010
PRE
Automated patient selection and care coaches to increase advance care planning for patients with cancer
2024-09-301
PRE
BIOGUIDE-X: A First-in-Human Study of the Performance of Positron Emission Tomography-Guided Radiation Therapy
2024-04-013
PRE
Cancer Informatics for Cancer Centers: Sharing Ideas on How to Build an Artificial Intelligence-Ready Informatics Ecosystem for Radiation Oncology
2023-09-010
OAAI